0 votes
asked by Question
Is CSL overpriced?

1 Answer

0 votes
answered by Expert
We examine the current analyst outlook on the biotech giant in the wake of its interim results. According to Bloomberg Data, the average 12-month price target on CSL currently sits at $314.06 per share – roughly 5.7% lower than the biotech giant's current share price.
Welcome to All about Travel site, where you can find questions and answers on everything about TRAVEL